The gene expression signature of genomic instability in breast cancer is an independent predictor of clinical outcome-Reference-Cited by-同舟云学术

The gene expression signature of genomic instability in breast cancer is an independent predictor of clinical outcome

Published:2009-04-01 Issue:7 Volume:124 Page:1552-1564
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Habermann Jens K.,Doering Jana,Hautaniemi Sampsa,Roblick Uwe J.,Bündgen Nana K.,Nicorici Daniel,Kronenwett Ulrike,Rathnagiriswaran Shruti,Mettu Rama K. R.,Ma Yan,Krüger Stefan,Bruch Hans-Peter,Auer Gert,Guo Nancy L.,Ried Thomas

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference47 articles.

1. Uses and abuses of tumor markers in the diagnosis, monitoring, and treatment of primary and metastatic breast cancer;Henry;Oncologist,2006

2. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications;Sorlie;Proc Natl Acad Sci USA,2001

3. A gene-expression signature as a predictor of survival in breast cancer;van de Vijver;N Engl J Med,2002

4. Gene expression profiling predicts clinical outcome of breast cancer;van 't Veer;Nature,2002

Cited by 103 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A genomic instability-associated lncRNA signature for predicting prognosis and biomarkers in lung adenocarcinoma;Scientific Reports;2024-06-24

2. TPX2 overexpression promotes sensitivity to dasatinib in breast cancer by activating YAP transcriptional signaling;Molecular Oncology;2024-02-15

3. Best Practices of Feature Selection in Multi-Omics Data;Research Anthology on Bioinformatics, Genomics, and Computational Biology;2023-12-29

4. Evaluation of miRNA-200c and βIII tubulin as promising markers for clinical decision making in locally advanced breast cancer patients receiving taxanes therapy;Gene Reports;2023-12

5. Characterization of genomic instability-related genes predicts survival and therapeutic response in lung adenocarcinoma;BMC Cancer;2023-11-16